663 related articles for article (PubMed ID: 25405855)
21. Two-stage induced differentiation of OCT4+/Nanog+ stem-like cells in lung adenocarcinoma.
Li R; Huang J; Ma M; Lou Y; Zhang Y; Wu L; Chang DW; Zhao P; Dong Q; Wu X; Han B
Oncotarget; 2016 Oct; 7(42):68360-68370. PubMed ID: 27588392
[TBL] [Abstract][Full Text] [Related]
22. Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway.
Yang J; Liao D; Chen C; Liu Y; Chuang TH; Xiang R; Markowitz D; Reisfeld RA; Luo Y
Stem Cells; 2013 Feb; 31(2):248-58. PubMed ID: 23169551
[TBL] [Abstract][Full Text] [Related]
23. Photodynamic therapy with 5-aminolevulinic acid (ALA) impairs tumor initiating and chemo-resistance property in head and neck cancer-derived cancer stem cells.
Yu CH; Yu CC
PLoS One; 2014; 9(1):e87129. PubMed ID: 24475244
[TBL] [Abstract][Full Text] [Related]
24. Differentiation of mouse embryonic stem cells after RNA interference-mediated silencing of OCT4 and Nanog.
Hough SR; Clements I; Welch PJ; Wiederholt KA
Stem Cells; 2006 Jun; 24(6):1467-75. PubMed ID: 16456133
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Cellular Transforming Activity of OCT4, NANOG, and SOX2 in Immortalized Astrocytes.
Seo S; Jeon HY; Kim H
DNA Cell Biol; 2017 Nov; 36(11):1000-1009. PubMed ID: 28933914
[TBL] [Abstract][Full Text] [Related]
26. Silencing of core transcription factors in human EC cells highlights the importance of autocrine FGF signaling for self-renewal.
Greber B; Lehrach H; Adjaye J
BMC Dev Biol; 2007 May; 7():46. PubMed ID: 17506876
[TBL] [Abstract][Full Text] [Related]
27. Evaluating of OCT-4 and NANOG was differentially regulated by a new derivative indole in leukemia cell line.
Karimabad MN; Mahmoodi M; Jafarzadeh A; Darehkordi A; Hajizadeh MR; Khorramdelazad H; Sayadi AR; Rahmani F; Hassanshahi G
Immunol Lett; 2017 Oct; 190():7-14. PubMed ID: 28690187
[TBL] [Abstract][Full Text] [Related]
28. TSSC3 overexpression reduces stemness and induces apoptosis of osteosarcoma tumor-initiating cells.
Huang Y; Dai H; Guo QN
Apoptosis; 2012 Aug; 17(8):749-61. PubMed ID: 22610481
[TBL] [Abstract][Full Text] [Related]
29. Significant association of combination of OCT4, NANOG, and SOX2 gene polymorphisms in susceptibility and response to treatment in North Indian breast cancer patients.
Tulsyan S; Agarwal G; Lal P; Mittal B
Cancer Chemother Pharmacol; 2014 Nov; 74(5):1065-78. PubMed ID: 25223935
[TBL] [Abstract][Full Text] [Related]
30. Loss of p16 expression is associated with the stem cell characteristics of surface markers and therapeutic resistance in estrogen receptor-negative breast cancer.
Arima Y; Hayashi N; Hayashi H; Sasaki M; Kai K; Sugihara E; Abe E; Yoshida A; Mikami S; Nakamura S; Saya H
Int J Cancer; 2012 Jun; 130(11):2568-79. PubMed ID: 21717460
[TBL] [Abstract][Full Text] [Related]
31. Cell fate determination factor Dachshund reprograms breast cancer stem cell function.
Wu K; Jiao X; Li Z; Katiyar S; Casimiro MC; Yang W; Zhang Q; Willmarth NE; Chepelev I; Crosariol M; Wei Z; Hu J; Zhao K; Pestell RG
J Biol Chem; 2011 Jan; 286(3):2132-42. PubMed ID: 20937839
[TBL] [Abstract][Full Text] [Related]
32. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma.
Ezeh UI; Turek PJ; Reijo RA; Clark AT
Cancer; 2005 Nov; 104(10):2255-65. PubMed ID: 16228988
[TBL] [Abstract][Full Text] [Related]
33. Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients.
Wang D; Lu P; Zhang H; Luo M; Zhang X; Wei X; Gao J; Zhao Z; Liu C
Oncotarget; 2014 Nov; 5(21):10803-15. PubMed ID: 25301732
[TBL] [Abstract][Full Text] [Related]
34. Sox2 expression in breast tumours and activation in breast cancer stem cells.
Leis O; Eguiara A; Lopez-Arribillaga E; Alberdi MJ; Hernandez-Garcia S; Elorriaga K; Pandiella A; Rezola R; Martin AG
Oncogene; 2012 Mar; 31(11):1354-65. PubMed ID: 21822303
[TBL] [Abstract][Full Text] [Related]
35. Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.
Gwak JM; Kim M; Kim HJ; Jang MH; Park SY
Oncotarget; 2017 May; 8(22):36305-36318. PubMed ID: 28422735
[TBL] [Abstract][Full Text] [Related]
36. Ovatodiolide Inhibits Breast Cancer Stem/Progenitor Cells through SMURF2-Mediated Downregulation of Hsp27.
Lu KT; Wang BY; Chi WY; Chang-Chien J; Yang JJ; Lee HT; Tzeng YM; Chang WW
Toxins (Basel); 2016 Apr; 8(5):. PubMed ID: 27136586
[TBL] [Abstract][Full Text] [Related]
37. Astaxanthin Reduces Stemness Markers in BT20 and T47D Breast Cancer Stem Cells by Inhibiting Expression of Pontin and Mutant p53.
Ahn YT; Kim MS; Kim YS; An WG
Mar Drugs; 2020 Nov; 18(11):. PubMed ID: 33233699
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the stemness potency of
Yousefnia S; Ghaedi K; Seyed Forootan F; Nasr Esfahani MH
Tumour Biol; 2019 Aug; 41(8):1010428319869101. PubMed ID: 31423948
[TBL] [Abstract][Full Text] [Related]
39. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract][Full Text] [Related]
40. Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog.
Paranjape AN; Balaji SA; Mandal T; Krushik EV; Nagaraj P; Mukherjee G; Rangarajan A
BMC Cancer; 2014 Oct; 14():785. PubMed ID: 25348805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
